CDKN2A, which encodes p16(INK4A) and p14(ARF) cell cycle-related tumor suppressors, was the first familial susceptibility gene and among the most highly penetrant with 30-90% risk of melanoma by age 80 years. The gene discussed is CDKN2A; the disease is melanoma.